GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » Institutional Ownership

Pro Medicus (ASX:PME) Institutional Ownership : 17.15% (As of May. 22, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pro Medicus's institutional ownership is 17.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pro Medicus's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pro Medicus's Float Percentage Of Total Shares Outstanding is 0.00%.


Pro Medicus Institutional Ownership Historical Data

The historical data trend for Pro Medicus's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Institutional Ownership Chart

Pro Medicus Historical Data

The historical data trend for Pro Medicus can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 16.60 16.74 17.23 16.80 16.69 17.01 17.06 17.21 17.85 17.15

Pro Medicus Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Pro Medicus (ASX:PME) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.